Sublingual vs Oral vs Inhaled THC: How Absorption Changes the Experience

Science & Education

35%

The same 10 milligrams of THC produces three different experiences depending on route, with bioavailability ranging from 4 to 20 percent orally to 10 to 35 percent inhaled.

Clin Pharmacol Ther, 1970

Clin Pharmacol Ther, 1970

View as image

The same 10 milligrams of THC can produce three meaningfully different experiences depending on whether you inhale it, swallow it, or hold it under your tongue. This is not marketing language. It is basic pharmacology. The route a drug takes to reach your brain determines how fast it arrives, what chemical form it takes when it gets there, how much of the original dose actually makes it into circulation, and how long the effects last. For cannabis consumers, understanding these differences is arguably more valuable than understanding any other variable, including strain, terpene profile, or even dose.

The Three Routes at a Glance

Science & Education

Three THC Routes: Speed, Strength, Duration

Inhaled (Smoke/Vape)3–10 min onset

Lungs → blood → brain

Active form: Delta-9-THC

Duration: 1–3 hrs

Bioavail: 10–35%

Sublingual (Under Tongue)15–45 min onset

Mouth mucosa → blood → brain

Active form: Mostly delta-9-THC

Duration: 2–6 hrs

Bioavail: 12–25% (est.)

Oral (Edible)45 min – 3 hrs onset

Gut → liver → blood → brain

Active form: 11-Hydroxy-THC (stronger)

Duration: 4–8 hrs

Bioavail: 4–20%

Why Edibles Feel Different

Your liver converts delta-9-THC to 11-hydroxy-THC — a metabolite that crosses the blood-brain barrier more efficiently and produces stronger effects. Edibles aren't just slow-acting inhalation. They're pharmacologically distinct.

Clin Pharmacol Ther (2007) • J Analytical ToxicolThree THC Routes: Speed, Strength, Duration

Before diving into the pharmacology, here is the practical summary. Inhaled THC (smoking or vaping) hits fast, peaks within minutes, and fades within a few hours. Oral THC (edibles and capsules) hits slowly, often taking an hour or more, but produces stronger and longer-lasting effects due to liver metabolism. Sublingual THC (tinctures held under the tongue) splits the difference, with a moderate onset and a duration that falls between the other two.

These are not subtle differences. The gap between a 5-minute onset and a 90-minute onset changes the entire dynamic of how you use cannabis: how you dose, how you plan your evening, and how likely you are to accidentally overconsume. The fact that oral THC is metabolized into a different, more potent compound in the liver means that edibles are not just "slow-acting inhaled THC." They are pharmacologically distinct experiences.

Inhaled THC: The Fast Lane to the Brain

When you smoke or vaporize cannabis, THC-laden aerosol enters the lungs and encounters an enormous surface area of thin-walled alveoli, the tiny air sacs where gas exchange occurs. The alveolar membrane is extraordinarily thin, roughly 0.1-0.5 micrometers, and is backed by a dense capillary network. THC diffuses across this membrane in seconds, enters the pulmonary blood supply, and is carried directly to the left side of the heart, which pumps it into systemic circulation. Within one or two heartbeats, THC-rich blood reaches the brain.

A classic pharmacokinetic study by Huestis and colleagues, published in the Journal of Analytical Toxicology, found that plasma THC concentrations peaked within 3-10 minutes of smoking, with some subjects reaching peak levels in under 5 minutes. This rapid onset is the defining feature of inhaled cannabis and the reason most experienced users describe smoking and vaping as the most "controllable" consumption method. You take a puff, wait a few minutes, assess where you are, and decide whether to take another. The feedback loop is tight enough to prevent most overconsumption events.

Bioavailability for inhaled THC ranges from roughly 10-35%, depending on inhalation depth, hold time, and the efficiency of the smoking or vaporizing device. A 2007 study by Abrams and colleagues in Clinical Pharmacology and Therapeutics found that vaporizers tended toward the higher end of this range compared to smoking, likely because combustion destroys some THC before it can be inhaled.

The duration of inhaled THC effects is typically 1-3 hours for the primary psychoactive experience, though residual effects (mild mood alteration, slight cognitive slowing) can persist for several hours beyond that. Plasma THC levels drop sharply after the initial peak due to rapid distribution into fatty tissues throughout the body. This redistribution, rather than metabolism, is the primary reason inhaled effects fade relatively quickly.

The main drawback of inhalation is respiratory exposure. Even without combustion (as with vaporizers), inhaling heated aerosol introduces compounds into the lungs that are not naturally present there. Long-term studies on cannabis vaping are still limited, though the existing evidence suggests that dry herb vaporization produces significantly fewer harmful byproducts than smoking.

Oral THC: The Liver Changes Everything

When you eat an edible, THC follows the same path as any other ingested substance. It enters the stomach, moves into the small intestine where most absorption occurs, and is transported via the portal vein to the liver before reaching systemic circulation. This journey through the liver before the drug reaches the rest of the body is called first-pass metabolism, and it fundamentally transforms the THC experience.

In the liver, the cytochrome P450 enzyme system, specifically the enzyme CYP2C9, converts delta-9-THC into 11-hydroxy-THC (11-OH-THC). This metabolite is not just a degradation product. It is pharmacologically active and, based on early animal and human studies, appears to cross the blood-brain barrier more readily than delta-9-THC itself. Research from the 1970s and 1980s, including work by Perez-Reyes and others, estimated that 11-hydroxy-THC may be 1.5 to 7 times more potent at the CB1 receptor than delta-9-THC.

This metabolic conversion is the reason edibles feel different from smoked cannabis, even at equivalent doses. It is not just that they are slower. The molecule reaching your brain is actually different. Many users describe the oral THC experience as more "body-heavy," more sedating, and more psychedelic than inhaled THC at similar doses. This makes pharmacological sense: a more potent CB1 agonist arriving over a longer timeframe would be expected to produce deeper, more sustained receptor activation.

Oral bioavailability is lower than inhaled, estimated at 4-20% in most studies. The wide range reflects enormous individual variability in gut absorption and liver enzyme activity. A 2019 study at the University of Minnesota demonstrated that consuming a cannabinoid capsule with a high-fat meal increased bioavailability by approximately 4-5 fold compared to taking it in a fasted state. Fat enhances absorption of lipophilic compounds like THC in the small intestine, which is why edible manufacturers often use fat-based carriers like coconut oil or butter.

Onset for oral THC is typically 30-90 minutes, though it can take up to 2 hours or longer in some individuals. Peak plasma levels occur around 1-3 hours after ingestion. Duration is 4-8 hours, significantly longer than inhalation, because the liver continues to convert THC to 11-hydroxy-THC as the compound absorbs over time, creating a sustained wave of active metabolite rather than a single sharp peak.

Sublingual THC: The Middle Path

Sublingual administration, holding a cannabis tincture or dissolvable strip under the tongue, occupies a pharmacological middle ground that is often misunderstood and frequently underappreciated.

The floor of the mouth is lined with thin mucous membranes supplied by a rich capillary network. When THC in a liquid carrier contacts these membranes, it can absorb directly into the bloodstream without passing through the gastrointestinal tract or the liver. This partial bypass of first-pass metabolism means that a greater proportion of the absorbed THC arrives at the brain as delta-9-THC rather than 11-hydroxy-THC.

The key word is "partial." Sublingual absorption is rarely complete. Some of the tincture inevitably mixes with saliva and is swallowed, at which point it enters the oral ingestion pathway and undergoes first-pass metabolism. The result is a hybrid pharmacokinetic profile: a faster-onset wave of delta-9-THC from sublingual absorption, followed by a slower wave of 11-hydroxy-THC from the swallowed portion. This two-phase absorption may explain why many tincture users describe the experience as having a quicker onset than edibles but a similar overall duration.

Quantitative data on sublingual cannabis bioavailability in humans is surprisingly limited. Most estimates are extrapolated from sublingual delivery of other drugs or from small cannabis-specific studies. Sativex (nabiximols), a THC/CBD oromucosal spray approved in several countries, has been studied more extensively than consumer tinctures, and its pharmacokinetic data suggests that sublingual and buccal absorption produces blood THC levels that fall between oral and inhaled administration in both magnitude and timing.

Onset for sublingual THC is typically 15-45 minutes, with peak effects around 1-2 hours. Duration ranges from 2-6 hours. These numbers place sublingual delivery squarely between inhalation and oral ingestion on every metric, which is precisely its appeal for users who want faster feedback than edibles provide without the respiratory involvement of inhalation.

Why 11-Hydroxy-THC Matters So Much

The conversion of delta-9-THC to 11-hydroxy-THC in the liver is the single most important pharmacological concept for understanding why different consumption methods feel different. It deserves a closer look.

11-hydroxy-THC was first identified and characterized in the early 1970s by researchers including Lemberger and colleagues. In controlled studies, intravenous administration of 11-hydroxy-THC produced faster onset of psychoactive effects than intravenous delta-9-THC at equivalent doses, suggesting more efficient penetration of the blood-brain barrier. Subsequent receptor binding studies supported the interpretation that 11-hydroxy-THC has higher affinity or efficacy at CB1 receptors, though the exact magnitude of the potency difference remains debated.

What this means practically is that oral cannabis consumption is not simply a slower version of inhaled cannabis. It is a different drug experience in a meaningful pharmacological sense. A 10 mg edible does not deliver 10 mg of delta-9-THC to the brain slowly. It delivers a variable amount of 11-hydroxy-THC to the brain over an extended period, and that metabolite hits harder per milligram than the parent compound.

This distinction explains several common observations. It explains why experienced smokers can sometimes be caught off guard by edibles. It explains why the same person may need 20 mg of inhaled THC but only 10 mg of oral THC to achieve a similar intensity of effect. And it explains why edible overconsumption tends to produce more intense anxiety and disorientation than smoking overconsumption: the molecule involved is simply more potent at the receptor level.

The Role of Individual Variability

Absorption is not just about the route. It is also about the person. Several biological variables create meaningful differences in how two people experience the same product consumed the same way.

CYP2C9 polymorphisms. The liver enzyme responsible for converting THC to 11-hydroxy-THC exists in multiple genetic variants. The most clinically relevant variant, CYP2C9*3, metabolizes THC substantially slower than the wild-type enzyme. People carrying this variant (roughly 15-20% of people of European descent, with different frequencies in other populations) may experience edibles as more intense and longer-lasting because the conversion to 11-hydroxy-THC is drawn out over a longer period. Conversely, they may accumulate more unmetabolized delta-9-THC, which could shift the qualitative character of the experience.

Gut microbiome and absorption. Emerging research suggests that the composition of gut bacteria may influence cannabinoid absorption in the small intestine. While this field is still young, it offers a plausible mechanism for the well-documented observation that edibles produce wildly different effects in different people even when controlling for dose, body weight, and tolerance.

Lung health and inhalation efficiency. For inhaled cannabis, the condition of the lungs matters. Individuals with reduced lung capacity, chronic bronchitis, or other respiratory conditions may absorb less THC per inhalation, effectively reducing their inhaled bioavailability. This is one reason why heavy smokers sometimes find that switching to a vaporizer actually increases the felt potency per unit of flower: cleaner vapor may be absorbed more efficiently than combustion smoke in compromised airways.

Tolerance and receptor state. CB1 receptor density, which determines how sensitive the brain is to any THC that arrives regardless of route, fluctuates based on recent cannabis use. PET imaging studies have demonstrated measurable downregulation of CB1 receptors in daily cannabis users, with recovery occurring over 2-4 weeks of abstinence. A person with downregulated receptors will experience any route as less potent, while someone with a full complement of receptors after a tolerance break will experience amplified effects from the same dose by any method.

Practical Implications for Choosing Your Route

Understanding absorption pharmacology transforms how you approach cannabis consumption. Here are the most actionable insights from the research.

Match the route to the situation. If you need rapid onset and short duration (a concert, a social event, an evening wind-down), inhalation gives you the most control. If you need sustained effects over many hours (chronic pain management, a full night of sleep), oral ingestion is better suited. If you want a middle ground with good dose control and no lung involvement, sublingual tinctures are the most versatile option.

Adjust dose expectations across routes. Do not assume that your 10 mg edible dose translates to a 10 mg sublingual dose or a 10 mg inhaled dose. The 11-hydroxy-THC conversion makes oral doses feel stronger per milligram than other routes. When switching between routes, start conservatively and titrate based on actual effects.

Account for food with oral and sublingual routes. A high-fat meal before an edible can dramatically increase absorption. If you typically take edibles on a full stomach and then try the same dose fasting, you may feel considerably less. If you normally take them fasting and then eat a fatty dinner beforehand, the same dose may feel overwhelming. Consistency in eating patterns improves dosing predictability.

Use the feedback loop to your advantage. The fast onset of inhalation makes it the safest route for exploring new products or returning after a tolerance break. You get clear information about your sensitivity within minutes, allowing you to stop before overconsumption. Edibles require patience and planning that inhalation does not, but they reward that patience with a longer, more sustained experience. The route you choose is ultimately a decision about which trade-offs best fit your needs on any given occasion.

The Bottom Line

Pharmacokinetic deep dive into three THC absorption routes. Inhaled: THC crosses alveolar membrane (0.1-0.5μm thick) in seconds; Huestis J Analytical Toxicology — peak plasma in 3-10min; bioavailability 10-35%; Abrams 2007 Clin Pharmacol Ther — vaporizers at higher end; duration 1-3h; fast decline from redistribution into fat not metabolism. Oral: first-pass metabolism via CYP2C9 converts delta-9-THC to 11-hydroxy-THC; Perez-Reyes early studies — 11-OH-THC 1.5-7x more potent at CB1; Lemberger 1970s — IV 11-OH-THC faster onset than IV delta-9-THC confirming better BBB penetration; bioavailability 4-20%; 2019 U of Minnesota — high-fat meal increased absorption 4-5x; onset 30-90min, duration 4-8h. Sublingual: partial first-pass bypass via oral mucosa capillaries; hybrid profile — fast delta-9 wave then slower 11-OH wave from swallowed portion; Sativex pharmacokinetics fall between oral and inhaled; onset 15-45min, duration 2-6h. Individual variability: CYP2C9*3 variant (15-20% Europeans) = slower metabolism/stronger edible effects; gut microbiome influence on absorption; lung health affects inhalation efficiency; CB1 downregulation from tolerance (PET imaging confirmed 2-4 week recovery). Practical: match route to situation, adjust dose across routes, account for food timing.

Frequently Asked Questions

Why do edibles feel so different from smoking?

The difference is pharmacological, not psychological. When you smoke or vape cannabis, THC reaches the brain as delta-9-THC within seconds. When you eat an edible, THC passes through the liver where the enzyme CYP2C9 converts a significant portion to 11-hydroxy-THC, a metabolite that crosses the blood-brain barrier more readily and is estimated to be 1.5 to 7 times more potent at CB1 receptors than delta-9-THC. You are literally experiencing a different active compound through each route. This is why edibles tend to feel more body-heavy, more sedating, and more psychedelic than inhaled cannabis at comparable doses. The slower onset (30 minutes to 2 hours versus seconds) and longer duration (4 to 8 hours versus 1 to 3 hours) further differentiate the experience.

What is the bioavailability of THC for each consumption method?

Bioavailability — the percentage of consumed THC that actually reaches systemic circulation — varies substantially by route. Inhaled THC has roughly 10 to 35 percent bioavailability, with vaporizers generally at the higher end because combustion destroys some THC before inhalation. Oral THC (edibles) has approximately 4 to 20 percent bioavailability, though the liver conversion to more potent 11-hydroxy-THC partially compensates for the lower absorption. Sublingual THC falls between the two, though precise human data remains limited. The wide ranges within each route reflect individual variability in lung function, liver enzyme activity, gut absorption, and food intake. A 2019 University of Minnesota study showed that a high-fat meal increased oral cannabinoid absorption by 4 to 5 times.

How long should you hold a tincture under your tongue?

Hold the liquid under your tongue for at least 60 seconds, ideally 90 seconds or longer. The sublingual mucous membranes are thin and well-supplied with capillaries, but absorption is not instantaneous — the longer THC remains in contact with these membranes, the more absorbs directly into the bloodstream before you swallow the remainder. Whatever you swallow enters the digestive pathway and undergoes first-pass liver metabolism, effectively becoming an edible. This creates a hybrid pharmacokinetic profile: a faster-onset wave of delta-9-THC from sublingual absorption followed by a slower wave of 11-hydroxy-THC from the swallowed portion. Maximizing sublingual contact time shifts the balance toward faster onset and a less intense but more controllable experience.

Can you switch between consumption methods without adjusting your dose?

No. Dose expectations should be adjusted when switching routes because the 11-hydroxy-THC conversion makes oral doses feel stronger per milligram than inhaled doses. A person who comfortably uses 20 milligrams of inhaled THC may find 20 milligrams in an edible overwhelming. When switching from inhalation to edibles or tinctures, start at roughly half your inhaled dose and titrate upward. When switching from edibles to inhalation, you may need a somewhat higher milligram amount to achieve similar intensity, though the faster onset means effects feel different regardless. Sublingual tinctures fall between the two. The safest approach with any new route is to start conservatively and use the feedback loop to find your effective dose.

Why do some people not feel anything from edibles?

Several biological factors can make edibles less effective for certain individuals. Variations in gut absorption, differences in CYP2C9 enzyme activity, and stomach acidity can all reduce how much THC reaches systemic circulation after oral ingestion. Some people have naturally faster hepatic clearance that metabolizes THC before it accumulates to psychoactive levels. Food timing also matters — taking an edible on an empty stomach may result in lower total absorption than taking it with a high-fat meal. Additionally, some commercially available edibles may contain less THC than labeled. For people who consistently feel little from edibles, sublingual tinctures offer an alternative oral route that partially bypasses the digestive variables, or they can try consuming edibles with a fatty meal to increase absorption.

Is sublingual THC safer than smoking or vaping?

From a respiratory perspective, yes. Sublingual absorption involves no lung exposure whatsoever — no smoke, no vapor, no heated aerosol. This eliminates the respiratory risks associated with inhaling combustion byproducts or heated compounds. However, "safer" depends on what you are measuring. Sublingual THC still carries the standard risks of any THC consumption: impairment, anxiety at higher doses, and potential for overconsumption. The partial bypass of first-pass metabolism means sublingual doses may feel somewhat less intense than equivalent oral doses, which can reduce overconsumption risk compared to edibles. The faster onset compared to edibles also provides a quicker feedback loop, making it easier to avoid taking too much. For people prioritizing lung health while wanting faster onset than edibles, sublingual delivery is the most favorable option currently available.